Efficacy of a Deep Cleansing Gel Containing 2% Salicylic Acid, 0.2% Zinc Gluconate and 0.05% Lipohydroxy Acid in the Management of Mild to Moderate Facial Acne

Last updated: March 9, 2023
Sponsor: Cosmetique Active International
Overall Status: Completed

Phase

N/A

Condition

Rash

Acne

Scalp Disorders

Treatment

N/A

Clinical Study ID

NCT05779085
090.324.003.12
  • Ages 13-26
  • All Genders

Study Summary

A clinical study with 56 healthy subjects (both sexes) aged between 13 to 25 years old. Subjects enrolled had a minimum of 5 inflammatory lesions (papules, nodules and pustules) and 10 non-inflammatory lesions (open and closed comedones), determined by dermatologist. The clinical evaluation considered in oiliness, shininess and global aspect of the skin too. Instrumental assessment of oiliness and shininess was performed, respectively, by Sebumeter and Sebutape.

IThe tested cleanser was used twice daily (morning and evening) during 28 days.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • subjects aged 13-25 years
  • mild to moderate acne on the face
  • signed informed consent

Exclusion

Exclusion Criteria:

  • subjects below 13 years and above 26 years
  • severe acne on the face

Study Design

Total Participants: 56
Study Start date:
April 08, 2013
Estimated Completion Date:
July 22, 2013

Connect with a study center

  • Carlos Tortely Hospital

    Niterói, 20231-048
    Brazil

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.